225 related articles for article (PubMed ID: 24975880)
1. Recurrent cerebral ischaemia in a pregnant woman with patent foramen ovale II° and thrombophilia.
Hecking C; Hendelmeier M; von Bardeleben R; Gröschel K; Schinzel H
Hamostaseologie; 2014; 34(3):239-43. PubMed ID: 24975880
[TBL] [Abstract][Full Text] [Related]
2. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
3. Clinical cure of severe, early onset preeclampsia with low molecular weight heparin therapy in primigravida with hyperreactio luteinalis and thrombophilia.
Saisto T; Tiitinen A; Ulander VM; Kaaja R
Hum Reprod; 2004 Mar; 19(3):725-8. PubMed ID: 14998977
[TBL] [Abstract][Full Text] [Related]
4. Cranial thromboembolism secondary to patent foramen ovale and deep venous thrombosis after cesarean section.
Bodur H; Caliskan E; Anik Y; Cakiroglu Y; Corakci A
Gynecol Obstet Invest; 2008; 65(4):258-61. PubMed ID: 18196909
[TBL] [Abstract][Full Text] [Related]
5. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies.
Hunt BJ; Doughty HA; Majumdar G; Copplestone A; Kerslake S; Buchanan N; Hughes G; Khamashta M
Thromb Haemost; 1997 Jan; 77(1):39-43. PubMed ID: 9031446
[TBL] [Abstract][Full Text] [Related]
6. Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: a case report and literature review.
Li Y; Margraf J; Kluck B; Jenny D; Castaldo J
Neurologist; 2012 Jan; 18(1):44-8. PubMed ID: 22217616
[TBL] [Abstract][Full Text] [Related]
7. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
[TBL] [Abstract][Full Text] [Related]
8. Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO).
Offelli P; Zanchetta M; Pedon L; Marzot F; Cucchini U; Pegoraro C; Iliceto S; Pengo V
Thromb Haemost; 2007 Oct; 98(4):906-7. PubMed ID: 17938820
[No Abstract] [Full Text] [Related]
9. [Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].
Paskaleva I; Karagiozova Zh; Doncheva E; Dineva D
Akush Ginekol (Sofiia); 2014; 53(2):3-10. PubMed ID: 25098102
[TBL] [Abstract][Full Text] [Related]
10. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
[TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy--a longitudinal safety study.
Blombäck M; Bremme K; Hellgren M; Siegbahn A; Lindberg H
Blood Coagul Fibrinolysis; 1998 Jan; 9(1):1-9. PubMed ID: 9607113
[TBL] [Abstract][Full Text] [Related]
12. The problem of risk assessment and prophylaxis of venous thromboembolism in pregnancy.
Krafft A
Thromb Haemost; 2007 Dec; 98(6):1155-6. PubMed ID: 18064306
[No Abstract] [Full Text] [Related]
13. Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy.
Jacobsen AF; Qvigstad E; Sandset PM
BJOG; 2003 Feb; 110(2):139-44. PubMed ID: 12618157
[TBL] [Abstract][Full Text] [Related]
14. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
15. [Thrombophilia and pregnancy].
Carlizza A
Minerva Cardioangiol; 2006 Dec; 54(6):799-801. PubMed ID: 17393610
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy.
Bremme K; van Rooijen M; Yu A; Blombäck M
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):149-55. PubMed ID: 11302478
[TBL] [Abstract][Full Text] [Related]
17. [Thrombophilia and HELLP syndrome in pregnancy - case report and overview of the literature].
Findeklee S; Costa SD; Tchaikovski SN
Z Geburtshilfe Neonatol; 2015 Feb; 219(1):45-51. PubMed ID: 25734477
[TBL] [Abstract][Full Text] [Related]
18. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A
Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303
[TBL] [Abstract][Full Text] [Related]
19. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
Fox NS; Laughon SK; Bender SD; Saltzman DH; Rebarber A
Obstet Gynecol; 2008 Oct; 112(4):884-9. PubMed ID: 18827132
[TBL] [Abstract][Full Text] [Related]
20. An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?
Rodger MA
Thromb Res; 2013 Jan; 131 Suppl 1():S25-7. PubMed ID: 23452735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
